IL-31 Rabbit Polyclonal Antibody

To Order:  patrick@cotinis.com

IL-31 Polyclonal Antibody

ABP57596-003ml 0.03ml
EUR 158
Description: A polyclonal antibody for detection of IL-31 from Human. This IL-31 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthetic peptide from human protein at AA range: 21-70

IL-31 Polyclonal Antibody

ABP57596-01ml 0.1ml
EUR 289
Description: A polyclonal antibody for detection of IL-31 from Human. This IL-31 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthetic peptide from human protein at AA range: 21-70

IL-31 Polyclonal Antibody

ABP57596-02ml 0.2ml
EUR 414
Description: A polyclonal antibody for detection of IL-31 from Human. This IL-31 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthetic peptide from human protein at AA range: 21-70

XMIR-31 RNA oligo miRNA-31-5p with Xmotif

XMIR-31 10 rxn
EUR 438

IL-31 Antibody

24390-100ul 100ul
EUR 390

IL-31 Antibody

24391-100ul 100ul
EUR 390

IL-31 Antibody

3745-002mg 0.02 mg
EUR 171.82
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.

IL-31 Antibody

3745-01mg 0.1 mg
EUR 436.42
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.

IL-31 Antibody

3747-002mg 0.02 mg
EUR 171.82
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.

IL-31 Antibody

3747-01mg 0.1 mg
EUR 436.42
Description: IL-31 Antibody: Interleukin-31 (IL-31) is a recently discovered T-cell cytokine closely related to IL-6 type cytokines and is preferentially produced by T helper type 2 cells. IL-31 activity is mediated through the ligand-induced oligomerization of a dimeric receptor complex containing IL-31 receptor A and oncostatin M receptor. In response to IL-31 binding, these proteins activate the JAK/STAT and the AKT signaling pathways. RNA levels of IL-31 receptor A and oncostatin M receptor are induced in activated monocytes but are expressed constitutively in epithelial cells. IL-31, when overexpressed in transgenic mice, results in the development of pruritis, alopecia, and skin lesions and in humans may result in atopic dermatitis, suggesting that IL-31 may represent a novel target for antipruritic drug development.

AXMIR-31 RNA oligo anti-miRNA-31-5p with Xmotif

AXMIR-31 10 reactions
EUR 438

IL-31

E21-053 10ug
EUR 343

Rabbit IL-31 ELISA Kit

ERTI0041 96Tests
EUR 521

Anti-IL-31 Antibody

A08339-1 100ug/vial
EUR 334

Anti-IL-31 antibody

STJ98951 200 µl
EUR 197
Description: Rabbit polyclonal to IL-31.

IL-31, Interleukin-31, human

RC212-42 2ug
EUR 104.38

Canine Interleukin 31(IL-31)

QY-E70194 96T
EUR 426

IL-31, Human

HY-P7217 50ug
EUR 762

IL-31 Peptide

3745P 0.05 mg
EUR 164.75
Description: (NT) IL-31 peptide

IL-31 Peptide

3747P 0.05 mg
EUR 164.75
Description: (IN) IL-31 peptide

XMIRXpress lentivector miRNA-31-5p with Xmotif

XMIRXP-31 10 ug
EUR 677

Recombinant Human Interleukin-31/IL-31

C053-10ug 10ug
EUR 202
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

Recombinant Human Interleukin-31/IL-31

C053-1mg 1mg
EUR 3145
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.

 

Scroll to Top